Local Institution
1 Hollow Lane
New Hyde Park, New York 11042
New Hyde Park, New York 11042
We've found
1 trials
at this facility
Hodgkin Disease Clinical Trial
Updated: 12/31/1969
A Study of Nivolumab Plus Brentuximab Vedotin in Patients Between 5 and 30 Years Old, With Hodgkin's Lymphoma (cHL), Relapsed or Refractory From First Line Treatment
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials